You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Higher-Risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tool for Breast Cancer in Higher-risk Women: A Prospective Study

Completed
  • Breast Cancer
  • CEDM
  • Kaohsiung, Taiwan
    Kaohsiung Veterans General Hospital
Mar 21, 2023

MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

Recruiting
  • Myelodysplastic Syndromes
  • Unrelated Umbilical Cord Blood
  • +3 more
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Oct 27, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

Not yet recruiting
  • Prostatic Cancer
  • High Dose Brachytherapy
  • Stereostatic Body Radiation Therapy
  • (no location specified)
Mar 3, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Identify Genes/Pathways Responsible for Progression From Low

Recruiting
  • Prostate Cancer Stage I
    • Taipei, Taiwan
      National Taiwan University
    Aug 11, 2022

    Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Rochester, Minnesota
    • +1 more
    Feb 15, 2023

    Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)

    Available
    • Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
    • Relapsed/Refractory Acute Myeloid Leukemia
    • Magrolimab
    • (no location specified)
    Jan 18, 2023

    Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

    Not yet recruiting
    • Higher Risk Myelodysplastic Syndrome
    • Chronic Myelomonocytic Leukemia
    • (no location specified)
    Jul 29, 2022

    Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

    Recruiting
    • Sickle Cell Disease
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndromes
    • Duarte, California
    • +3 more
    Nov 21, 2023

    Tool for Interstitial Lung Disease in People With Rheumatoid

    Not yet recruiting
    • Arthritis, Rheumatoid
    • Lung Diseases, Interstitial
      • (no location specified)
      May 16, 2023

      Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

      Not yet recruiting
      • Untreated Myelodysplastic Syndrome
      • Onureg + Venetoclax
      • Angers, France
      • +9 more
      Mar 13, 2023

      Chronic Myeloid Leukemia Trial in France (Venetoclax)

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Amiens, France
      • +14 more
      Mar 3, 2023

      Apixaban Compared to Warfarin in Non-valvular Atrial

      Not yet recruiting
      • Non-valvular Atrial Fibrillation
        • (no location specified)
        Jul 20, 2022

        Postpartum Hemorrhage Trial (Tranexamic acid, Placebo)

        Not yet recruiting
        • Postpartum Hemorrhage
        • Tranexamic acid
        • Placebo
        • (no location specified)
        Nov 11, 2022

        High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

        Active, not recruiting
        • High Risk Myelodysplastic Syndrome
        • Houston, Texas
          M D Anderson Cancer Center
        Feb 2, 2022

        MDS Trial in Tampa, Saint Louis, Seattle (CPX-351, Research skin biopsy, Research blood draw)

        Active, not recruiting
        • Myelodysplastic Syndromes
        • Tampa, Florida
        • +2 more
        Apr 1, 2022

        MDS Trial in New Haven (CPX-351)

        Withdrawn
        • MDS
        • New Haven, Connecticut
          Yale University; Smilow Cancer Center
        Jan 6, 2022

        AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

        Recruiting
        • AML, Adult
        • +3 more
        • Shreveport, Louisiana
        • +3 more
        Jul 19, 2022

        Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in United

        Completed
        • Chronic Myelomonocytic Leukemia
        • +4 more
        • Los Angeles, California
        • +4 more
        Oct 5, 2022

        Intestinal Malrotation With a Higher Risk of Volvulus.

        Completed
        • Postnatal Complication
        • Mesenteric Pregnancy
        • Ultrasound exam
        • +3 more
        • Montpellier, France
          Uhmontpellier
        Dec 22, 2021

        Breast Cancer, Malignant Tumor of Breast Trial in Cleveland (Immediate Breast Reconstruction, Delayed Breast Reconstruction,

        Withdrawn
        • Breast Cancer
        • Malignant Neoplasm of Breast
        • Immediate Breast Reconstruction
        • +2 more
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        May 16, 2022

        Antenatal Ultrasound in Localization of Intestinal Structures

        Recruiting
        • Pregnancy Related
        • Reference ultrasound examination
        • Montpellier, France
          University Hospital of Montpellier
        Dec 2, 2021